Fundraising Fox
/Companies
Sign in

ProFound Therapeutics

Founded 2022 · 51 employees on LinkedIn · 2 known investors

Find your way into ProFound Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

1,054 people can intro you to Vini

Ask Mark Springel to introduce you to Vini Mani

You →Mark · together at Harvard GSAS Journal of Emerging Investigators, Inc →Vini

154 people can intro you to Avak

Ask Jamie Chen to introduce you to Avak Kahvejian

You →Jamie · together at Cygnal Therapeutics →Avak

Sign up to find every way you can get introduced to ProFound Therapeutics

  • Your email: who you already know at ProFound Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ProFound Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

ProFound Therapeutics discovers and develops therapeutic candidates by analyzing the expanded human proteome, identifying novel proteins from previously uncharacterized genetic sequences that can serve as drug targets for cancer, immune disorders, and metabolic diseases.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

ProFound Therapeutics was founded in 2022 by Avak Kahvejian, Yann Echelard, Vini Mani, and Erica Weinstein.

AKAvak Kahvejian
Avak KahvejianCo-founder, ChairmanAvak Kahvejian is Co-founder and Chairman of ProFound Therapeutics, which discovers and develops therapeutic candidates by analyzing the expanded human proteome to identify novel drug targets. He previously worked at Flagship Pioneering, where he helped conceive and launch platform companies built on new biological mechanisms and biotechnologies.
YE
Yann EchelardCo-founder
VMVini Mani
Vini ManiCo-founderVini Mani is an immunologist and co-founder of ProFound Therapeutics, which analyzes the expanded human proteome to identify novel proteins as drug targets for cancer, immune disorders, and metabolic diseases. She serves as a board member of Science Club for Girls.
EWErica Weinstein
Erica WeinsteinCo-founder

Board

NANoubar Afeyan
Noubar AfeyanInvestor at Flagship Pioneering

Investors · 2

Modi Ventureslisted by Modi VenturesHouston

How we know: Modi Ventures's portfolio page · Not right? Tell us

Founder mafia

2 people who came through ProFound Therapeutics went on to found or lead other companies.

Noubar AfeyanCo-founder and ChairmanFounded Cellarity +15Avak KahvejianCo-founder, ChairmanFounded Etiome +5

In the news

Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK - BioSpacebiospace.com · Nov 2025

Frequently asked questions

What does ProFound Therapeutics do?
ProFound Therapeutics discovers and develops therapeutic candidates by analyzing the expanded human proteome, identifying novel proteins from previously uncharacterized genetic sequences that can serve as drug targets for cancer, immune disorders, and metabolic diseases.
Who founded ProFound Therapeutics?
ProFound Therapeutics was founded by Avak Kahvejian, Yann Echelard, Vini Mani, Erica Weinstein in 2022.
Who are ProFound Therapeutics's investors?
ProFound Therapeutics's investors include Flagship Pioneering, Modi Ventures.